NovaBay Pharmaceuticals, Inc. Logo

NovaBay Pharmaceuticals, Inc.

Develops and commercializes eyecare, skincare, and wound care products.

NBY | US

Overview

Corporate Details

ISIN(s):
US66987P2011
LEI:
Country:
United States of America
Address:
2000 POWELL STREET, SUITE 1150, 94608 EMERYVILLE

Description

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NovaBay Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NovaBay Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NovaBay Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

IDEAYA Biosciences, Inc. Logo
Clinical-stage oncology company developing targeted therapies using synthetic lethality.
United States of America
IDYA
Idorsia Ltd Logo
Biopharmaceutical company developing small-molecule medicines for multiple therapeutic areas.
Switzerland
IDIA
ILDONG HOLDINGS CO.,LTD  Logo
A holding company managing a diversified healthcare group in pharmaceuticals and bioscience.
South Korea
000230
IL DONG PHARMACEUTICAL CO., LTD. Logo
Develops, manufactures, and commercializes a broad range of healthcare products.
South Korea
249420
ILSUNG IS CO., LTD. Logo
Develops and manufactures antibiotics, cardiovascular agents, and anesthetics.
South Korea
003120
ILYANG PHARMACEUTICAL CO.,LTD Logo
Develops and manufactures a diverse range of pharmaceuticals and consumer health products.
South Korea
007570
I-Mab Logo
Global biotech company developing bispecific antibodies for immuno-oncology.
United States of America
IMAB
ImageneBio, Inc. Logo
Develops therapeutics for immunological, autoimmune, and inflammatory diseases.
United States of America
IMA
IMGT Corporation Limited Logo
Develops a drug delivery platform using focused ultrasound and nanotechnology.
South Korea
456570
Immatics N.V. Logo
Clinical-stage biopharma developing T cell receptor immunotherapies for cancer.
United States of America
IMTX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.